TrialThe Lancet. Respiratory medicine2021

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.

Jean-Claude Tardif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.